(Q36693368)

15 August 2017

1 reference

title

Particle size analysis in pharmaceutics: principles, methods and applications (English)

1 reference

15 August 2017

Boris Y Shekunov

1

1 reference

15 August 2017

Pratibhash Chattopadhyay

series ordinal

2

1 reference

15 August 2017

Henry H Y Tong

series ordinal

3

1 reference

15 August 2017

Albert H L Chow

series ordinal

4

1 reference

15 August 2017

publication date

27 December 2006

1 reference

15 August 2017

published in

Pharmaceutical Research

1 reference

15 August 2017

volume

24

1 reference

15 August 2017

issue

2

1 reference

15 August 2017

page(s)

203-227

1 reference

Particle size analysis: AAPS workshop report, cosponsored by the Food and Drug Administration and the United States Pharmacopeia

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11095-006-9146-7

Micrometer-scale particle sizing by laser diffraction: critical impact of the imaginary component of refractive index

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-006-9146-7

Fundamental effects of particle morphology on lung delivery: predictions of Stokes' law and the particular relevance to dry powder inhaler formulation and development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-006-9146-7

Characterization of submicron systems via optical methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-006-9146-7

Comparison of particle sizing techniques in the case of inhalation dry powders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-006-9146-7

Pulmonary drug delivery systems: recent developments and prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-006-9146-7

Regional lung deposition and bronchodilator response as a function of beta2-agonist particle size

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-006-9146-7

Therapeutic significance of distal airway inflammation in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-006-9146-7

Improved lung delivery from a passive dry powder inhaler using an Engineered PulmoSphere powder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-006-9146-7

Pulmonary delivery of deslorelin: large-porous PLGA particles and HPbetaCD complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-006-9146-7

Physicochemical characterization of a new respirable form of nedocromil.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-006-9146-7

Ultrafine particle-lung interactions: does size matter?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-006-9146-7

Particle interactions involved in aerosol dispersion of ternary interactive mixtures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-006-9146-7

Modification of electrostatic charge on inhaled carrier lactose particles by addition of fine particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-006-9146-7

Effect of carrier size on the dispersion of salmeterol xinafoate from interactive mixtures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-006-9146-7

The formulation of powder inhalation systems containing a high mass of nedocromil sodium trihydrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-006-9146-7

Nasal delivery of human growth hormone: in vitro and in vivo evaluation of a thiomer/glutathione microparticulate delivery system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-006-9146-7

Transport of PLA-PEG particles across the nasal mucosa: effect of particle size and PEG coating density.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-006-9146-7

Nasal delivery of insulin using chitosan microspheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-006-9146-7

Formulation of a dry powder influenza vaccine for nasal delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-006-9146-7

Polydisperse powder mixtures: effect of particle size and shape on mixture stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-006-9146-7

Influence of crystal shape on the tableting performance of L-lysine monohydrochloride dihydrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-006-9146-7

In vitro-in vivo correlations for lipophilic, poorly water-soluble drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-006-9146-7

Characterization of an active pharmaceutical ingredient by its dissolution properties: amoxicillin trihydrate as a model drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-006-9146-7

Nanoparticle engineering processes for enhancing the dissolution rates of poorly water soluble drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-006-9146-7

Calculation of the required size and shape of hydroxypropyl methylcellulose matrices to achieve desired drug release profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-006-9146-7

Relationship between drug percolation threshold and particle size in matrix tablets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-006-9146-7

Evaluation of sodium alginate as drug release modifier in matrix tablets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-006-9146-7

In vitro release of sodium diclofenac from a central core matrix tablet aimed for colonic drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-006-9146-7

Tableting of Eudragit RS and propranolol hydrochloride solid dispersion: effect of particle size, compaction force, and plasticizer addition on drug release.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-006-9146-7

Nanosuspensions in drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-006-9146-7

Skin penetration and distribution of polymeric nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-006-9146-7

Nanomedicine: current status and future prospects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-006-9146-7

Nanoparticles of biodegradable polymers for new-concept chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-006-9146-7

Toxic potential of materials at the nanolevel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-006-9146-7

Acute pulmonary toxicity caused by exposure to colloidal silica: particle size dependent pathological changes in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-006-9146-7

Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-006-9146-7

Physical characterization of pharmaceutical solids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-006-9146-7

Aerodynamic particle size analysis of aerosols from pressurized metered-dose inhalers: comparison of Andersen 8-stage cascade impactor, next generation pharmaceutical impactor, and model 3321 Aerodynamic Particle Sizer aerosol spectrometer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-006-9146-7

Calibration and use of the Aerodynamic Particle Sizer (APS 3300)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-006-9146-7

A review of the terms agglomerate and aggregate with a recommendation for nomenclature used in powder and particle characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-006-9146-7

Nanoparticles of poorly water-soluble drugs prepared by supercritical fluid extraction of emulsions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-006-9146-7

Effect of amino acids on the dispersion of disodium cromoglycate powders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-006-9146-7

Assuring quality and performance of sustained and controlled release parenterals: EUFEPS workshop report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-006-9146-7

Amplitude and phase microscopy for sizing of spherical particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-006-9146-7

Characterization of a surface modified dry powder inhalation carrier prepared by "particle smoothing".

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-006-9146-7

Physicochemical characterisation of cationic polybutylcyanoacrylate-nanoparticles by fluorescence correlation spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-006-9146-7

Aerodynamic sizing of metered dose inhalers: an evaluation of the Andersen and Next Generation pharmaceutical impactors and their USP methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-006-9146-7

Thermal analysis of trace levels of polymorphic impurity in salmeterol xinafoate samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-006-9146-7

Relationship of stage mensuration data to the performance of new and used cascade impactors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-006-9146-7

The Influence of Particle Size Distribution and Surface Roughness of Carrier Particles on the in vitro Properties of Dry Powder Inhalations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-006-9146-7

APS Response to Nonspherical Particles and Experimental Determination of Dynamic Shape Factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-006-9146-7

Liposomal amikacin dry powder inhaler: effect of fines on in vitro performance

21 January 2018

1 reference

12 December 2020

Recent advances in pulmonary drug delivery using large, porous inhaled particles

1 reference

12 December 2020

Transdermal delivery of mixnoxidil with block copolymer nanoparticles

1 reference

12 December 2020

Nanoparticle technology for drug delivery: from nanoparticles to cutting-edge delivery strategies - part I

1 reference

12 December 2020

Study of the critical points of HPMC hydrophilic matrices for controlled drug delivery

1 reference

12 December 2020

Protein deposition from dry powder inhalers: fine particle multiplets as performance modifiers

1 reference

12 December 2020

Nebulization of NanoCrystals: production of a respirable solid-in-liquid-in-air colloidal dispersion

1 reference

12 December 2020

Large porous particles for pulmonary drug delivery

1 reference

12 December 2020

Formulation and optimization of controlled release mucoadhesive tablets of atenolol using response surface methodology.

1 reference

12 December 2020

10.1007/S11095-006-9146-7

Identifiers

DOI

1 reference

15 August 2017

1 reference